A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)

11 Mar 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · PREVENTION study · Malaria,Falciparum · Phase 1 · Enrollment 56 · Sponsor: University of Oxford

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 11 Mar 2026. The item focuses on A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine). Open the detail page to review the full original feed content.